About usOur teamOur pipelineContact us

Abstracts & publications

September 2022
LRRC15+ myofibroblasts dictate the stromal setpoint to suppress tumour immunity
Read moreRead more
October 2021
There is a world beyond αvβ3: Multimeric ligands for imaging of the integrin subtypes αvβ6, αvβ8,αvβ3 and α5β1 by positron emission tomography
Read moreRead more
June 2021
Preclinical development and characterisation of 99mTc-NM-01 for SPECT/CT imaging of human PD-L1
Read moreRead more
June 2021
European Molecular Imaging Meeting 2021 – 68-Trivehexin enables PET/CT imaging of carcinomas in humans by targeting the “cancer integrin” αvβ6
Read moreRead more
June 2021
European Molecular Imaging Meeting 2021 – Peptide trimers as complex systems: Optimization of pharmacokinetics by simple phenylalanine-tyrosine exchange
Read moreRead more
June 2021
PET/CT imaging of pancreatic carcinoma targeting the “cancer integrin” αvβ6
Read moreRead more
April 2021
PSA-targeted Alpha-, Beta-, and Positron emitting immunotheranostics in murine prostate cancer models and non human primates
Read moreRead more
February 2021
Radiotheranostic targeting of fPSA
Read moreRead more

Sign up to our mailing list.

Receive all the latest news from Radiopharm Theranostics.